The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 20, 2012

Filed:

Jul. 23, 2009
Applicants:

Jean-michel Adam, Rosenau, FR;

Johannes Aebi, Binningen, CH;

Alfred Binggeli, Binningen, CH;

Luke Green, Basel, CH;

Guido Hartmann, Loerrach, DE;

Hans P. Maerki, Basel, CH;

Patrizio Mattei, Riehen, CH;

Fabienne Ricklin, Hombourg, FR;

Olivier Roche, Folgensbourg, FR;

Inventors:

Jean-Michel Adam, Rosenau, FR;

Johannes Aebi, Binningen, CH;

Alfred Binggeli, Binningen, CH;

Luke Green, Basel, CH;

Guido Hartmann, Loerrach, DE;

Hans P. Maerki, Basel, CH;

Patrizio Mattei, Riehen, CH;

Fabienne Ricklin, Hombourg, FR;

Olivier Roche, Folgensbourg, FR;

Assignee:

Hoffmann-La Roche Inc., Nutley, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 241/08 (2006.01); C07D 243/08 (2006.01); C07D 401/06 (2006.01); C07D 401/14 (2006.01); C07D 413/06 (2006.01); A61K 31/551 (2006.01); A61K 31/4965 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention is concerned with novel heterocyclyl compounds of formula (I): wherein A, X, R, R, R, R, R, R, R, R, m, n and p are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor and may be used as medicaments.


Find Patent Forward Citations

Loading…